Med Life Future Growth
Future criteria checks 5/6
Med Life is forecast to grow earnings and revenue by 71.1% and 9.9% per annum respectively. EPS is expected to grow by 62.7% per annum. Return on equity is forecast to be 27% in 3 years.
Key information
71.1%
Earnings growth rate
62.72%
EPS growth rate
| Healthcare earnings growth | 19.2% |
| Revenue growth rate | 9.9% |
| Future return on equity | 27.05% |
| Analyst coverage | Low |
| Last updated | 08 Jun 2026 |
Recent future growth updates
Recent updates
High-Complexity Healthcare Expansion And Digitalization Will Support Long-Term Earnings Potential
Catalysts About Med Life Med Life operates a private healthcare network that includes clinics, hospitals, laboratories, pharmacies and corporate medical services in Romania. What are the underlying business or industry changes driving this perspective?
Future Expansion Into Complex Services Will Strain Margins And Limit Earnings Potential
Catalysts About Med Life Med Life operates a private healthcare network in Romania across clinics, hospitals, laboratories, pharmacies and corporate medical services. What are the underlying business or industry changes driving this perspective?Investors Appear Satisfied With Med Life S.A.'s (BVB:M) Prospects As Shares Rocket 26%
Med Life S.A. ( BVB:M ) shares have continued their recent momentum with a 26% gain in the last month alone. The last...We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Shareholders Should Be Pleased With Med Life S.A.'s (BVB:M) Price
When close to half the companies in the Healthcare industry in Romania have price-to-sales ratios (or "P/S") below...Be Wary Of Med Life (BVB:M) And Its Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Why Investors Shouldn't Be Surprised By Med Life S.A.'s (BVB:M) 25% Share Price Surge
BVB:M 1 Year Share Price vs Fair Value Explore Med Life's Fair Values from the Community and select yours Med Life S.A...Med Life S.A.'s (BVB:M) Price In Tune With Revenues
When you see that almost half of the companies in the Healthcare industry in Romania have price-to-sales ratios (or...Is Med Life S.A. (BVB:M) Trading At A 41% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Med Life fair value estimate is RON9.09 Current share price of...The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More
Med Life S.A. ( BVB:M ) shares have continued their recent momentum with a 25% gain in the last month alone. Taking a...Is Med Life (BVB:M) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Is Med Life (BVB:M) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Returns Are Gaining Momentum At Med Life (BVB:M)
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
In this article we are going to estimate the intrinsic value of Med Life S.A. ( BVB:M ) by taking the expected future...Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Does Med Life (BVB:M) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Med Life's (BVB:M) Returns On Capital Are Heading Higher
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 4,271 | 265 | 367 | 602 | 1 |
| 12/31/2027 | 3,886 | 140 | 278 | 504 | 2 |
| 12/31/2026 | 3,519 | 77 | 202 | 427 | 2 |
| 3/31/2026 | 3,250 | 8 | 6 | 202 | N/A |
| 12/31/2025 | 3,174 | 11 | -5 | 223 | N/A |
| 9/30/2025 | 3,109 | 5 | -12 | 246 | N/A |
| 6/30/2025 | 2,988 | 2 | -46 | 215 | N/A |
| 3/31/2025 | 2,847 | 24 | -5 | 270 | N/A |
| 12/31/2024 | 2,716 | 25 | 30 | 286 | N/A |
| 9/30/2024 | 2,562 | 22 | 10 | 272 | N/A |
| 6/30/2024 | 2,458 | 18 | 26 | 274 | N/A |
| 3/31/2024 | 2,336 | 11 | -15 | 223 | N/A |
| 12/31/2023 | 2,222 | 4 | -36 | 184 | N/A |
| 9/30/2023 | 2,116 | -11 | 40 | 268 | N/A |
| 6/30/2023 | 2,020 | -3 | -10 | 179 | N/A |
| 3/31/2023 | 1,921 | 12 | 23 | 212 | N/A |
| 12/31/2022 | 1,810 | 32 | 15 | 185 | N/A |
| 9/30/2022 | 1,725 | 64 | 10 | 112 | N/A |
| 6/30/2022 | 1,623 | 80 | 83 | 202 | N/A |
| 3/31/2022 | 1,520 | 98 | 122 | 209 | N/A |
| 1/1/2022 | 1,438 | 103 | 130 | 227 | N/A |
| 9/30/2021 | 1,359 | 107 | 103 | 185 | N/A |
| 6/30/2021 | 1,295 | 112 | 67 | 172 | N/A |
| 3/31/2021 | 1,160 | 83 | 47 | 148 | N/A |
| 1/1/2021 | 1,087 | 57 | 40 | 129 | N/A |
| 9/30/2020 | 1,033 | 36 | 49 | 145 | N/A |
| 6/30/2020 | 974 | 16 | 77 | 134 | N/A |
| 3/31/2020 | 1,007 | 18 | 63 | 113 | N/A |
| 12/31/2019 | 975 | 14 | N/A | 107 | N/A |
| 9/30/2019 | 939 | 20 | N/A | 76 | N/A |
| 6/30/2019 | 902 | 16 | N/A | 71 | N/A |
| 3/31/2019 | 861 | 11 | N/A | N/A | N/A |
| 1/1/2019 | 804 | 13 | N/A | 52 | N/A |
| 9/30/2018 | 745 | 8 | N/A | 47 | N/A |
| 6/30/2018 | 699 | 5 | N/A | 41 | N/A |
| 3/31/2018 | 657 | 5 | N/A | N/A | N/A |
| 1/1/2018 | 628 | 4 | N/A | 36 | N/A |
| 9/30/2017 | 610 | 3 | N/A | 42 | N/A |
| 6/30/2017 | 577 | -2 | N/A | 39 | N/A |
| 3/31/2017 | 539 | -6 | N/A | N/A | N/A |
| 1/1/2017 | 508 | -5 | N/A | 43 | N/A |
| 9/30/2016 | 469 | -1 | N/A | 39 | N/A |
| 12/31/2015 | 396 | 9 | N/A | 42 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: M's forecast earnings growth (71.1% per year) is above the savings rate (6.8%).
Earnings vs Market: M's earnings (71.1% per year) are forecast to grow faster than the RO market (8.5% per year).
High Growth Earnings: M's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: M's revenue (9.9% per year) is forecast to grow faster than the RO market (5.7% per year).
High Growth Revenue: M's revenue (9.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: M's Return on Equity is forecast to be high in 3 years time (27%)
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/28 02:01 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Med Life S.A. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Caius Rapanu | Erste Group Bank AG |
| Ionut Gavris | Ipopema Securities S.A. |
| Elias New | ODDO BHF Corporate & Markets |